These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 16404786)

  • 21. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Severe depression with risperidone-induced EPS in an elderly schizoaffective patient.
    Benazzi F
    Can J Psychiatry; 1996 Apr; 41(3):196-7. PubMed ID: 8722655
    [No Abstract]   [Full Text] [Related]  

  • 23. Visual hallucinations and amnesia associated with zolpidem triggered by fluvoxamine: a possible interaction.
    Kito S; Koga Y
    Int Psychogeriatr; 2006 Dec; 18(4):749-51. PubMed ID: 17026779
    [No Abstract]   [Full Text] [Related]  

  • 24. Misdiagnosis and exacerbation of unusual obsessive-compulsive disorder presentation with risperidone and clozapine in an adolescent girl - A case report.
    Marsanić VB; Aukst-Margetić B; Grgić N; Kusmić E
    Coll Antropol; 2011 Jan; 35 Suppl 1():293-6. PubMed ID: 21648350
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Symptomatic bradyarrhythmia secondary to risperidone.
    Goyal RS; Goyal SB
    Am J Psychiatry; 2003 Dec; 160(12):2243. PubMed ID: 14638604
    [No Abstract]   [Full Text] [Related]  

  • 26. Efficacy and safety of risperidone in the treatment of schizoaffective disorder: initial results from a large, multicenter surveillance study. Group for the Study of Risperidone in Affective Disorders (GSRAD).
    Vieta E; Herraiz M; Fernández A; Gastó C; Benabarre A; Colom F; Martínez-Arán A; Reinares M
    J Clin Psychiatry; 2001 Aug; 62(8):623-30. PubMed ID: 11561935
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Choreatic symptoms during and after treatment with paliperidone and escitalopram.
    Hüther R; Gebhart C; Mirisch S; Bäuml J; Förstl H
    Pharmacopsychiatry; 2008 Sep; 41(5):203-4. PubMed ID: 18763225
    [No Abstract]   [Full Text] [Related]  

  • 28. Switching between clozapine and risperidone treatment.
    Gardner DM; Baldessarini RJ; Benzo J; Zarate CA; Tohen M
    Can J Psychiatry; 1997 May; 42(4):430-1. PubMed ID: 9161773
    [No Abstract]   [Full Text] [Related]  

  • 29. [Brief case report. Duloxetine in Cotard syndrome].
    Kozian R
    Psychiatr Prax; 2005 Nov; 32(8):412-3. PubMed ID: 16342026
    [No Abstract]   [Full Text] [Related]  

  • 30. Antipsychotic agents and bipolar disorder.
    Tohen M; Zarate CA
    J Clin Psychiatry; 1998; 59 Suppl 1():38-48; discussion 49. PubMed ID: 9448668
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effectiveness of financial incentives for long-acting injectable antipsychotic adherence in patients with psychotic and bipolar disorders: a systematic review protocol.
    Dennis R; Christian R; Palokas M
    JBI Database System Rev Implement Rep; 2019 Jan; 17(1):43-48. PubMed ID: 30629042
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics and safety of combination therapy with lithium and risperidone.
    Demling JH; Huang ML; Remmerie B; Mannaert E; Sperling W
    Pharmacopsychiatry; 2006 Nov; 39(6):230-1. PubMed ID: 17124646
    [No Abstract]   [Full Text] [Related]  

  • 33. Catatonia and mild neuroleptic malignant syndrome after initiation of long-acting injectable risperidone: case report.
    Mall GD; Hake L; Benjamin AB; Adityanjee A
    J Clin Psychopharmacol; 2008 Oct; 28(5):572-3. PubMed ID: 18794658
    [No Abstract]   [Full Text] [Related]  

  • 34. Neuroleptic malignant syndrome induced by quetiapine and fluvoxamine.
    Matsumoto R; Kitabayashi Y; Nakatomi Y; Tsuchida H; Fukui K
    Am J Psychiatry; 2005 Apr; 162(4):812. PubMed ID: 15800166
    [No Abstract]   [Full Text] [Related]  

  • 35. [Depot antipsychotics in the year 2011].
    Knegtering H; Oolders H; Ruijsink MA; van der Moolen AE
    Tijdschr Psychiatr; 2011; 53(2):95-105. PubMed ID: 21319066
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A case of pulmonary thromboembolism and rhabdomyolysis during therapy with mirtazapine and risperidone.
    Zink M; Knopf U; Argiriou S; Kuwilsky A
    J Clin Psychiatry; 2006 May; 67(5):835. PubMed ID: 16841636
    [No Abstract]   [Full Text] [Related]  

  • 37. Clinical guidelines: Dosing and switching strategies for long-acting risperidone.
    Marder SR; Conley R; Ereshefsky L; Kane JM; Turner MS
    J Clin Psychiatry; 2003; 64 Suppl 16():41-6. PubMed ID: 14680418
    [No Abstract]   [Full Text] [Related]  

  • 38. Risperidone-induced rabbit syndrome in mood disorder.
    Eren I; Ozcankaya R; Altinyazar V
    Eur Psychiatry; 2004 Nov; 19(7):452-3. PubMed ID: 15504657
    [No Abstract]   [Full Text] [Related]  

  • 39. [Long-acting injectable risperidone: naturalistic study in three hospitals in Aquitaine].
    Raignoux C; Dusouchet T; Bret P; Queuille E; Biscay ML; Caron J; Bret MC
    Encephale; 2007 Dec; 33(6):973-81. PubMed ID: 18789790
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risperidone-Induced Acute Urinary Retention in a Patient With Major Depressive Disorder With Psychotic Features: a Case Report.
    Ou H; Chang HA; Kao YC; Tzeng NS
    Am J Ther; 2021 Jun; 28(5):e585-e587. PubMed ID: 34224426
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.